Loading...
IceCure Medical Ltd
ICCM•NASDAQ
Healthcare
Medical - Devices
$0.96
$0.010(1.04%)
IceCure Medical Ltd (ICCM) Financial Performance & Statements
Review IceCure Medical Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
1.92%
↑ 1.92%
Operating Income Growth
-0.77%
↓ 0.77%
Net Income Growth
-4.55%
↓ 4.55%
Operating Cash Flow Growth
-0.34%
↓ 0.34%
Operating Margin
-476.91%
↓ 476.91%
Gross Margin
44.11%
↑ 44.11%
Net Profit Margin
-465.41%
↓ 465.41%
ROE
-156.37%
↓ 156.37%
ROIC
-221.80%
↓ 221.80%
IceCure Medical Ltd (ICCM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for IceCure Medical Ltd stock.
Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Revenue | $3.29M | $3.23M | $3.08M | $4.14M |
Cost of Revenue | $1.84M | $1.93M | $1.64M | $1.94M |
Gross Profit | $1.45M | $1.30M | $1.45M | $2.19M |
Gross Profit Ratio | $0.44 | $0.40 | $0.47 | $0.53 |
R&D Expenses | $7.10M | $8.27M | $9.12M | $5.88M |
SG&A Expenses | $10.05M | $8.60M | $9.06M | $6.04M |
Operating Expenses | $17.15M | $16.88M | $18.18M | $11.92M |
Total Costs & Expenses | $18.99M | $18.80M | $19.82M | $13.86M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $239000.00 | $0.00 |
Depreciation & Amortization | $332000.00 | $323000.00 | $248000.00 | $127000.00 |
EBITDA | -$15.36M | -$15.25M | -$16.49M | -$9.60M |
EBITDA Ratio | -$4.67 | -$4.72 | -$5.35 | -$2.32 |
Operating Income | -$15.70M | -$15.58M | -$16.74M | -$9.72M |
Operating Income Ratio | -$4.77 | -$4.82 | -$5.43 | -$2.35 |
Other Income/Expenses (Net) | $378000.00 | $924000.00 | -$239000.00 | -$171000.00 |
Income Before Tax | -$15.32M | -$14.65M | -$16.98M | -$9.89M |
Income Before Tax Ratio | -$4.65 | -$4.54 | -$5.50 | -$2.39 |
Income Tax Expense | $0.00 | $0.00 | $239000.00 | $171000.00 |
Net Income | -$15.32M | -$14.65M | -$17.22M | -$10.07M |
Net Income Ratio | -$4.65 | -$4.54 | -$5.58 | -$2.43 |
EPS | -$0.31 | -$0.32 | -$0.47 | -$0.35 |
Diluted EPS | -$0.31 | -$0.32 | -$0.47 | -$0.35 |
Weighted Avg Shares Outstanding | $50.88M | $45.64M | $37.02M | $28.55M |
Weighted Avg Shares Outstanding (Diluted) | $50.88M | $45.64M | $37.02M | $28.55M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan